Please login to the form below

Not currently logged in

Bayer partners with Glamour on female empowerment

Campaign to support the contraception Skyla


Bayer HealthCare has partnered with women's magazine Glamour for a campaign to celebrate the achievements of women in the US via a national competition.

The partners launched the Skyla Make Your Mark contest this week, which aims to seek out women who are pursuing something unique or brave, inspiring others along the way.

Skyla – the product that gives its name to the contest - is an IUD contraceptive marketed by Bayer Healthcare. It was introduced to the market in 2013.

Entrants must submit a brief essay and photo or video about how they are making their mark to the Glamour website. The winner will be awarded a $5,000 grant, a trip to New York to attend Glamour's Women of the Year gala and will be featured on a promotional page in an upcoming issue of the magazine.

To help promote the contest, Bayer Healthcare and Glamour have enlisted the actress Zosia Mamet from HBO TV series Girls.

Mamet, said: “We all have stories and they all deserve to be heard. Glamour, Bayer and I want to give women a platform to share their stories and to show the world how they're making their mark. We all make our marks in different ways.”

'Make Your Mark' closes on October 1, 2014.

Article by
Kirstie Pickering

11th September 2014

From: Marketing



Featured jobs

Subscribe to our email news alerts


Add my company
Wilmington Healthcare

A heritage to envy Wilmington Healthcare brings together the data intelligence specialisms of Binley’s, NHiS, Wellards and HSJ to create...

Latest intelligence

Waking the sleeping giant
The lights are coming on for healthcare delivery in Africa...
How to get rep buy-in for multi-channel
How do you manage a team who may be resistant to change?...
Blog: Digital therapeutics: within our reach?
Digital therapeutics is a hot topic right now. By using digital technology to manage, treat or even prevent chronic conditions, digital therapeutics is promising to revolutionise healthcare. But is this...